您当前的位置:
InVivo Plus Anti-Mouse CTLA-4 Antibody (9D9)
目录号 : KE9981 纯度 : >95% as determined by SDS-PAGE

InVivo Plus Anti-Mouse CTLA-4 Antibody (9D9) 是一种靶向小鼠 CTLA-4(CD152)的单克隆抗体,CTLA-4 是一种免疫检查点受体。该抗体可阻断 CTLA-4/B7 相互作用,并耗竭肿瘤内调节性T细胞(Tregs),从而增强小鼠模型中的抗肿瘤T细胞免疫反应。Anti-Mouse CTLA-4 Antibody(Clone 9D9)可用于免疫学和癌症相关研究。

规格 价格 是否有货 数量
1mg
In-stock
5mg
In-stock
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性

InVivo Plus Anti-Mouse CTLA-4 Antibody (9D9) is a mouse monoclonal antibody detecting CTLA-4 in ELISA, FCM, Functional assay, Research in vivo. Suitable for Mouse.

分子量
~150 kDa
储存方式

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

研究背景
Cytotoxic T-lymphocyte protein 4 (CD152/CTLA4) is a ~24 kDa protein. Inhibitory receptor acting as a major negative regulator of T-cell responses. Acts as a decoy receptor: the affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28. CD152 is the therapeutic target of ipilimumab (Yervoy).
种属反应性
Mouse
宿主
Mouse
同种型
Mouse IgG2b kappa
表达系统
HEK293
Accession号
P09793
应用
ELISA, FCM, Functional assay, Research in vivo
性状
Liquid
保存溶液
0.01M PBS pH 7.4.
基因 ID
12477
纯度
>95% as determined by SDS-PAGE.
内毒素含量
< 1 EU/mg as determined by LAL method.
靶标
CD152, CTLA-4, CTLA4, Cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4
克隆号
9D9
克隆类型
Monoclonal
推荐同型对照抗体
IgG2a (LALA-PG) kappa

纯度: >95% as determined by SDS-PAGE

暂无相关参考文献
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
动物实验计算换算器
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。

配置后的溶液总体积:

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。